Immunomodulatory effects of Yu-Ping-Feng formula on primary Sjögren syndrome: interrogating the T-cell response
- PMID: 38953166
- DOI: 10.1093/jleuko/qiae155
Immunomodulatory effects of Yu-Ping-Feng formula on primary Sjögren syndrome: interrogating the T-cell response
Abstract
Ethnopharmacological treatments have shown beneficial effects in the clinical practice of autoimmune disorders. However, the underlying mechanism of immunomodulatory effects remains challenging, given the complicate composition of herbal medicines. Here, we developed an immunological approach to interrogate the T helper cell response. Through data mining, we hypothesized that Chinese medicine formula Yu-Ping-Feng might be a promising candidate for treating primary Sjögren syndrome, a common autoimmune disease manifested by exocrine gland dysfunction. We took advantage of a mouse model of experimental Sjögren syndrome that we previously established for Yu-Ping-Feng formula treatment. Yu-Ping-Feng therapy ameliorated the experimental Sjögren syndrome pathology in mice with active disease, showing improved salivary function and decreased serum levels of autoantibodies. Phenotypic analysis suggested that both effector T and B cells were significantly suppressed. Using coculture assay and adoptive transfer models, we demonstrated that Yu-Ping-Feng formula directly restrained effector/memory T-cell expansion and differentiation into Th17 and T follicular helper cells, the key subsets in experimental Sjögren syndrome pathogenesis. Importantly, we recruited 20 patients with primary Sjögren syndrome and conducted a pilot study of 8-wk therapy of Yu-Ping-Feng formula. Yu-Ping-Feng treatment effectively improved fatigue symptoms and exocrine gland functions, as well as reduced serum IgG/IgA levels, while effector T- and B-cell subsets were significantly decreased. There was a trend of reduction on disease activity, but not statistically significant. Together, our findings suggest a novel approach to assess the immunomodulatory effects of Yu-Ping-Feng formula, which may be favorable for patients with autoimmune disorders.
Keywords: Chinese medicine formula; Sjögren syndrome; T cell; Yu-Ping-Feng; adoptive transfer.
© The Author(s) 2024. Published by Oxford University Press on behalf of Society for Leukocyte Biology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Conflict of interest statement
Conflict of interest statement. None declared.
Comment in
-
Yu-Ping-Feng formula: a promising traditional Chinese medicine for the treatment of primary Sjögren's syndrome.J Leukoc Biol. 2025 Feb 13;117(2):qiae193. doi: 10.1093/jleuko/qiae193. J Leukoc Biol. 2025. PMID: 39215570 No abstract available.
Similar articles
-
Effects of Gan lian Yu ping feng powder on the antibody titers to infectious laryngotracheitis vaccine and some nonspecific immune indexes in chickens.Afr J Tradit Complement Altern Med. 2013 May 16;10(4):70-7. doi: 10.4314/ajtcam.v10i4.12. eCollection 2013. Afr J Tradit Complement Altern Med. 2013. PMID: 24146504 Free PMC article.
-
The Ancient Chinese Decoction Yu-Ping-Feng Suppresses Orthotopic Lewis Lung Cancer Tumor Growth Through Increasing M1 Macrophage Polarization and CD4+ T Cell Cytotoxicity.Front Pharmacol. 2019 Nov 8;10:1333. doi: 10.3389/fphar.2019.01333. eCollection 2019. Front Pharmacol. 2019. PMID: 31780946 Free PMC article.
-
B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome.J Rheumatol. 2017 Jan;44(1):49-58. doi: 10.3899/jrheum.160313. Epub 2016 Nov 15. J Rheumatol. 2017. PMID: 28042126
-
Effects of Yu-Ping-Feng polysaccharides on animal growth performance and immune function: a review.Front Vet Sci. 2023 Sep 20;10:1260208. doi: 10.3389/fvets.2023.1260208. eCollection 2023. Front Vet Sci. 2023. PMID: 37799408 Free PMC article. Review.
-
The T cell in Sjogren's syndrome: force majeure, not spectateur.J Autoimmun. 2012 Sep;39(3):229-33. doi: 10.1016/j.jaut.2012.05.019. Epub 2012 Jun 17. J Autoimmun. 2012. PMID: 22709856 Free PMC article. Review.
Cited by
-
Calycosin synergizes with methotrexate in the treatment of Sjögren's disease by targeting BATF in T follicular helper cells.Acta Pharmacol Sin. 2025 Jul;46(7):1990-2005. doi: 10.1038/s41401-025-01536-4. Epub 2025 Apr 3. Acta Pharmacol Sin. 2025. PMID: 40181166
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous